• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immun Inflamm Dis . Differential expression of Type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal ant

tetano

Editor, Senior Moderator
Immun Inflamm Dis


. 2023 Oct;11(10):e968.
doi: 10.1002/iid3.968. Differential expression of Type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies

Luca Maddaloni[SUP] 1 [/SUP], Letizia Santinelli[SUP] 1 [/SUP], Ginevra Bugani[SUP] 1 [/SUP], Elio G Cacciola[SUP] 1 [/SUP], Alessandro Lazzaro[SUP] 1 [/SUP], Chiara M Lofaro[SUP] 1 [/SUP], Sara Caiazzo[SUP] 1 [/SUP], Federica Frasca[SUP] 2 [/SUP], Matteo Fracella[SUP] 2 [/SUP], Camilla Ajassa[SUP] 1 [/SUP], Cristiana Leanza[SUP] 1 [/SUP], Anna Napoli[SUP] 3 [/SUP], Lilia Cinti[SUP] 3 [/SUP], Aurelia Gaeta[SUP] 1 [/SUP], Guido Antonelli[SUP] 2 [/SUP], Giancarlo Ceccarelli[SUP] 1 4 [/SUP], Claudio M Mastroianni[SUP] 1 [/SUP], Carolina Scagnolari[SUP] 2 [/SUP], Gabriella d'Ettorre[SUP] 1 [/SUP]



Affiliations
Abstract

Introduction: Considering the reported efficacy of monoclonal antibodies (mAbs) directed against the Spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in reducing disease severity, the aim of this study was to investigate the innate immune response before and after mAbs treatment in 72 vaccinated and 31 unvaccinated SARS-CoV-2 patients.
Methods: The mRNA levels of IFN-I, IFN-related genes and cytokines were evaluated using RT/real-time quantitative PCR.
Results: Vaccinated patients showed increased rate of negative SARS-CoV-2 PCR tests on nasopharyngeal swab compared with unvaccinated ones after mAbs treatment (p = .002). Unvaccinated patients had lower IFN-α/ω and higher IFN-related genes (IFNAR1, IFNAR2, IRF9, ISG15, ISG56 and IFI27) and cytokines (IL-6, IL-10 and TGF-β) mRNA levels compared to vaccinated individuals before mAbs (p < .05 for all genes). Increased IFN-α/ω, IFNAR1, IFNAR2 and IRF9 levels were observed in unvaccinated patients after mAbs treatment, while the mRNA expression ISGs and IL-10 were reduced in all patients.
Conclusion: These data suggest that anti-S vaccinated patients have increased levels of innate immune genes compared to unvaccinated ones. Also, gene expression changes in IFN genes after mAbs administration are different according to the vaccination status of patients.

Keywords: SARS-CoV-2; Type I interferons; interferon-stimulated genes; monoclonal antibodies.

 
Back
Top Bottom